Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Pathology|October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancerShona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
The Journal of Molecular Diagnostics : JMD|January 7, 2018
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and PyrosequencingAshleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, et al.
Oncotarget|November 8, 2017
Sensitive droplet digital PCR method for detection of <i>TERT</i> promoter mutations in cell free DNA from patients with metastatic melanomaAshleigh C McEvoy, Leslie Calapre, Michelle R Pereira, et al.
Molecular Oncology|October 13, 2018
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanomaLeslie Calapre, Tindaro Giardina, Cleo Robinson, et al.
Cancers|December 19, 2020
The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond <i>BRAF</i> Mutant DetectionGabriela Marsavela, Peter A Johansson, Michelle R Pereira, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|October 6, 2016
Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicityDavid Larson, Amy Powers, Jean-Paul Ambrosi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2013
A genome-wide association study for malignant mesothelioma riskGemma Cadby, Sutapa Mukherjee, A W Bill Musk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2020
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination ImmunotherapyGabriela Marsavela, Jenny Lee, Leslie Calapre, et al.
BMJ Open|May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot studyBenjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Pageof 3